JLB & Associates’s St Jude Medical STJ Stock Holding History

JLB & Associates’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-9,798	Closed	-$605K	–	78
2015 Q4	$605K	Sell	9,798 -283	-3%	-$17.8K	0.19%	64
2015 Q3	$636K	Hold	10,081	–	–	0.21%	64
2015 Q2	$736K	Hold	10,081	–	–	0.23%	63
2015 Q1	$659K	Hold	10,081	–	–	0.21%	67
2014 Q4	$655K	Hold	10,081	–	–	0.22%	67
2014 Q3	$606K	Sell	10,081 -400	-4%	-$26.1K	0.22%	67
2014 Q2	$725K	Sell	10,481 -300	-3%	-$19.4K	0.26%	63
2014 Q1	$704K	Hold	10,781	–	–	0.26%	66
2013 Q4	$667K	Hold	10,781	–	–	0.25%	65
2013 Q3	$578K	Sell	10,781 -275	-2%	-$14.2K	0.24%	65
2013 Q2	$504K	Buy	+11,056	New	+$479K	0.23%	65

Other funds holding STJ

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JLB & Associates's STJ Position: Q1 2016 in Review

JLB & Associates sold out of St Jude Medical (STJ) in Q1 2016, closing a stake of 9,798 shares — an estimated $605K sold.

JLB & Associates first reported a position in STJ in Q2 2013 and held it in 11 quarters. The position peaked at $736K in Q2 2015. 570 funds tracked by Wall St. Rank hold STJ as of Q1 2016.

JLB & Associates reported no remaining St Jude Medical position as of Q1 2016 after selling out during the quarter.
JLB & Associates sold 9,798 St Jude Medical shares in Q1 2016, an estimated $605K.
JLB & Associates first reported a position in St Jude Medical in Q2 2013 and held it in 11 quarters.
JLB & Associates's St Jude Medical position peaked at $736K in Q2 2015.
570 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2016.

Based on JLB & Associates's 13F filing for Q1 2016, filed 8 Apr 2016.